HOME >> MEDICINE >> NEWS
Under the surface, the brain seethes with undiscovered activity

There's an old myth that we only use 10 percent of our brains, but researchers at the University of Rochester have found in reality that roughly 80 percent of our cognitive power may be cranking away on tasks completely unknown to us.

Curiously, this clandestine activity does not exist in the youngest brains, leading scientists to believe that the mysterious goings-on that absorb the majority of our minds are dedicated to subconsciously reprocessing our initial thoughts and experiences. The research, which has possible profound implications for our very basis of understanding reality, appears in last week's issue of the journal Nature.

"We found neural activity that frankly surprised us," says Michael Weliky, associate professor of brain and cognitive sciences at the University of Rochester. "Adult ferrets had neural patterns in their visual cortex that correlated very well with images they viewed, but that correlation didn't exist at all in very young ferrets, suggesting the very basis of comprehending vision may be a very different task for young brains versus old brains."

A second surprise was in store for Weliky. Placing the ferrets in a darkened room revealed that older ferrets' brains were still humming along at 80 percent as if they were processing visual information. Since this activity was absent in the youngsters, Weliky and his colleagues were left to wonder: What is the visual cortex so busy processing when there's no image to process?

Initially, Weliky's research was aimed at studying whether visual processing bore any resemblance to the way real-world images appear. This finding may help lead to a better understanding of how neurons decode our world and how our perception of reality is shaped.

Weliky, in a bit of irony, set 12 ferrets watching the reality-stretching film The Matrix. He recorded how their brains responded to the film, as well as to a null pattern like enlarged television static, and a darkened room.
'"/>

Contact: Jonathan Sherwood
jonathan.sherwood@rochester.edu
585-273-4726
University of Rochester
8-Oct-2004


Page: 1 2 3 4

Related medicine news :

1. Understanding how vulnerabilities may keep women in abusive relationships
2. From town planning to intimate sex: Understanding the risks in our lives
3. Understanding how prostaglandin prevents gut injury during radiation therapy
4. Undertreatment spurs new arrests among drug ofenders diverted under Californias Proposition 36
5. Understanding epilepsy
6. The long view: Understanding why cancer strikes late
7. Understanding the autoimmune response in type 1 diabetes
8. Understanding nerve degeneration in spastic paraplegia
9. Understanding how lymph nodes respond to infection may redefine how immune system functions
10. Understanding Alzheimers disease: Animal research points to new direction for therapy
11. Understanding genetic cancer risk might not help smokers kick the habit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Under the surface the brain seethes with undiscovered activity

(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: